Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-26T06:22:04.889Z Has data issue: false hasContentIssue false

Early results of Pulsta® transcatheter heart valve in patients with enlarged right ventricular outflow tract and severe pulmonary regurgitation due to transannular patch – CORRIGENDUM

Published online by Cambridge University Press:  09 December 2022

Rights & Permissions [Opens in a new window]

Abstract

Type
Corrigendum
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press

The authors apologise that a within the section, valve implantation procedure, it was incorrectly written that ‘Patients heparinised 50 mg/kg and the dose has determined according to the activated clotting time, which should be between 150 and 250 seconds.’

The correct procedure should have been listed as ‘Patients heparinised 50 Unit/kg and the dose has determined according to the activated clotting time, which should be between 150 and 250 seconds.’

The article has been updated to reflect the correct information.

References

Odemis, E., Yenidogan, I., & Kizilkaya, M. (2022). Early results of Pulsta® transcatheter heart valve in patients with enlarged right ventricular outflow tract and severe pulmonary regurgitation due to transannular patch. Cardiology in the Young, 1-9. doi: 10.1017/S1047951122003511 CrossRefGoogle Scholar